CME Group files to expand FICC cross-margining to end-user clients

Published 29/09/2025, 13:06
CME Group files to expand FICC cross-margining to end-user clients

NEW YORK - CME Group announced Monday it has filed with the CFTC to expand its existing cross-margining agreement with The Depository Trust & Clearing Corporation (DTCC).

The proposed enhancement aims to provide increased margin savings and capital efficiencies to end-user clients by December 2025, subject to regulatory approval. DTCC plans to make a similar filing with the SEC in the near future. This initiative aligns with CME Group’s strong operational efficiency, reflected in its impressive 100% gross profit margin.

The expansion would allow eligible clients with positions at both CME Group and DTCC’s Fixed Income Clearing Corporation (FICC) Government Securities Division to benefit from capital efficiencies when trading U.S. Treasury securities and CME Group interest rate futures with offsetting risk exposures.

To participate, clients will need to use the same dually-registered Futures Commission Merchant and broker/dealer at both clearinghouses. Under the arrangement, clients could elect to have positions in eligible products at both institutions carried in a cross-margining account and margined based on their combined risk.

The filing represents a significant step toward implementing the cross-margining capabilities first announced by the two market infrastructure providers. The initiative would extend to end-users the type of margin efficiencies previously available to clearing members.

CME Group operates as the world’s leading derivatives marketplace, while DTCC serves as the premier post-trade market infrastructure for the global financial services industry.

This information is based on a press release statement issued by CME Group.

In other recent news, CME Group reported its second-highest August average daily volume (ADV) of 28.1 million contracts, highlighting a strong performance in its derivatives marketplace. The company achieved a record monthly ADV in cryptocurrency products, with 411,000 contracts representing a notional value of $14.9 billion. CME Group also announced plans to introduce options on Solana and XRP futures, set to launch on October 13, 2025, pending regulatory approval. Additionally, the company reached significant milestones in its credit futures, with trading volume surpassing 450,000 contracts and open interest representing over $700 million in notional value. In collaboration with FanDuel, CME Group is developing event-based trading contracts aimed at retail investors, anticipated to launch later this year. Furthermore, CME Group declared a third-quarter dividend of $1.25 per share, payable on September 25, 2025, to shareholders of record as of September 9. These developments reflect CME Group’s ongoing expansion and innovation across various market segments.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.